Press release
Therapeutic Nuclear Medicines Market is expected to grow at a CAGR of 11.1% over the forecast period 2021–2028
Increasing acceptance of therapeutic nuclear medicines (or radiopharmaceuticals) among industry experts will remain a prominent factor encouraging their adoption. Though associated with a negligible risk factor, radiopharmaceuticals are likely to witness growing recommendation owing to no proven significant adverse effects.In the backdrop of the growing criticality of a more reliable, safer, and lesser harmful line of treatment for cancers, therapeutic nuclear medicines are being increasingly perceived as the potential treatment for cancer patients. Moreover, consistently surging instances of bone metastases further supports adoption growth, in the therapeutic nuclear medicines market.
Gain complete access to the report @ https://www.futuremarketinsights.com/reports/therapeutic-nuclear-medicines-market
Just-under 10% Annual Growth Projected for Radiopharmaceuticals Adoption
A recent market research intelligence by Future Market Insights focuses on the deep-dive evaluation of global therapeutic nuclear medicines landscape, emphasizing the analysis of the most influential factors responsible for surging acceptance of radiopharmaceuticals in treating a range of cancers and a few other chronic conditions.
The study projects robust progress for the global radiopharmaceuticals market in coming years, reportedly driven by remarkable adoption in the treatment of prostate cancer. In 2019, the global demand for therapeutic nuclear medicines is expected to grow at a 9.7% annual rate, and maximum adoption is estimated by cancer research institutes at a global level.
• North America, jointly with Western Europe, represents more than 65% share of the total market value.
• Outpacing developed regional markets, the radiopharmaceuticals market in China and emerging economies across Asia Pacific, Latin America, and Middle East & Africa are slated for higher year on year revenue growth of over 12% in 2019 and ahead.
• China is reportedly the most lucrative market for penetration of therapeutic nuclear medicines, which is attributed to an expanding cancer patient pool in the country and a consistently surging rate of radiopharmaceuticals recommendation.
To remain ‘ahead’ of your competitors, request for a sample - https://www.futuremarketinsights.com/reports/sample/rep-gb-2930
Competitive Landscape
The competition section of the therapeutic nuclear medicines market report features the profiles of the key players of the therapeutic nuclear medicines market based on their product offerings, market shares, marketing approach and differential strategies.
Prominent Players:
• Bayer AG
• Novartis AG
• GE Healthcare
• Curium Pharmaceuticals
• Jubilant DraxImage
• Spectrum Pharmaceuticals
• Progenics Pharmaceuticals, Inc.
• ANSTO
• Lantheus Medical Imaging, Inc.
• Eckert & Ziegler
• International Isotopes Inc.
Top Three Companies Account for More than 87% Market Value Share
A highly consolidated marketplace, global therapeutic nuclear medicines landscape is dominated by Bayer AG that currently accounts for just-under 80% revenue share in market. The top three players include GE Healthcare and Novartis AG other than Bayer, which collectively cover over 87% of the total valuation of radiopharmaceuticals market. While exceptional sales and success rate of Xofigo have been prominently retaining Bayer’s top position in the global market, strategic acquisitions are identified to be the key strategy behind Novartis’ success at a global level.
Thorough assessment of the competitive landscape of global therapeutic medicines market reveals a few prominent developmental strategies adopted by a majority of key companies operating in radiopharmaceuticals landscape –
• Investments in R&D of targeted cancer
therapeutics
• Stronger supply chain and more streamlined
distribution network
• Improved flagship product sales
• Strategic collaborations with
pharma/biopharmaceutical companies
• Contractual relationships with
domestic/regional stakeholders
• Strategic deals with internationally
recognized cancer research institutes
Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-2930
Over 20% Growth Forecast for Erbium-169
Radium-223 has been the highest recommended type of radionucleotide in radiopharmaceuticals market. While it currently accounts for a whopping 78% share in the global market revenue, it is more likely that Erbium-169 that has been witnessing higher traction in recent past would witness relatively higher revenue growth in coming years. The report forecasts over 20% year on year revenue growth for Erbium-169 in 2019.
Exceptional Growth Projections for Thyroid & Brain Cancer
While over half the global market value is accounted by the adoption of therapeutic nuclear medicines for treatment of prostate cancer, bone metastases also accounts for sizable revenue generation in the market. Brain tumor and thyroid cancer are likely to emerge highly lucrative targets for manufacturers of therapeutic nuclear medicines, according to the report.
Investments in R&D of targeted cancer therapeutics
Stronger supply chain and more streamlined distribution network
Improved flagship product sales
Strategic collaborations with pharma/biopharmaceutical companies
Contractual relationships with domestic/regional stakeholders
Strategic deals with internationally recognized cancer research institutes
Key Segment
Based on the treatment type
• Radium-223
• Iodine-131
• Leutitium-177
• Yttrium-90
• Samarium-153
• Strontium-89
• Rhenium-188+ Rhenium-186
• Erbium-169
• Phosphorus-32
• Others
Based on the indication
• prostate cancer
• painful bone metastases
• thyroid cancer
• neuroblastoma
• synovitis
• non-Hodgkins lymphoma
• hepatic metastases
• brain tumour
• others
Based on the distribution channel
• hospitals
• ambulatory surgical centres
• cancer research institutes
For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-2930
Based on the region
• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia-Pacific Excluding Japan (APECJ)
• China
• Japan
• Middle East & Africa (MEA)
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Therapeutic Nuclear Medicines Market is expected to grow at a CAGR of 11.1% over the forecast period 2021–2028 here
News-ID: 2504419 • Views: …
More Releases from Future Market Insights
AI in IoT Market Set to Reach USD 172.8 Billion by 2035 with 6.4% CAGR Amid Risi …
The AI in IoT market is witnessing rapid expansion as enterprises across industries increasingly integrate artificial intelligence with Internet of Things (IoT) systems. Valued at USD 92.9 billion in 2025, the market is projected to reach USD 172.8 billion by 2035, representing a compound annual growth rate of 6.4%. The integration of AI into IoT infrastructure enables predictive analytics, real-time monitoring, and automated control across multiple applications, transforming how businesses…
Catalog Management System Market Poised to Reach USD 4.2 Billion by 2035 with Ad …
The catalog management system (CMS) market is experiencing steady and strategic growth, with its value projected to rise from USD 1.9 billion in 2025 to USD 4.2 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8.1%. The market expansion is primarily fueled by businesses' growing need for centralized product information, streamlined digital operations, and enhanced customer experiences across increasingly complex sales channels.
As e-commerce continues to penetrate global…
HIFI Electronics Market Set to Double by 2035, Driven by Premium Audio and Techn …
The global HIFI electronics market is poised for remarkable growth over the next decade, projected to expand from USD 17,243.4 million in 2025 to USD 37,227.2 million by 2035. This impressive growth trajectory, representing an absolute increase of nearly USD 19,983.8 million and a compound annual growth rate (CAGR) of 8%, reflects the rising global appetite for premium audio experiences and high-fidelity sound reproduction across personal and professional applications.
The expansion…
Interrogation Table Market to Reach USD 435.7 Million by 2035, Driven by Securit …
The global interrogation table market, valued at USD 321.1 million in 2025, is set to grow steadily to USD 435.7 million by 2035, registering a moderate CAGR of 3.1%. This trajectory reflects a market gradually approaching maturity, where incremental demand for specialized security furniture outweighs rapid expansion. The early stage from 2025 to 2028 is expected to see modest increases in annual revenues, primarily linked to new infrastructure development across…
More Releases for Bay
Bay Area Moving Services Revolutionizes Commercial Moving Solutions for Bay Area …
San Francisco, CA - Bay Area Moving Services, a premier provider of professional moving solutions, is proud to announce the expansion of its comprehensive commercial moving services designed to meet the diverse needs of businesses throughout the Bay Area. With a steadfast commitment to efficiency, reliability, and customer satisfaction, Bay Area Moving Services is setting new standards in the commercial moving industry, ensuring seamless transitions for businesses of all sizes.
As…
bay leaf manifestation
Unlock the Power of Manifestation with Bay Leaves - A Comprehensive Guide
Are you ready to manifest your desires with greater ease and effectiveness? Look no further than the power of bay leaf manifestation.
Bay leaf manifestation is an ancient technique that has been used for centuries to manifest one's desires. It consists of writing your intention or desire on a bay leaf and placing it in a prominent location where you…
Bay & Bay Transportation Named Safest Fleet, Division IV, By Truckload Carriers …
Bay and Bay recently named Safest Fleet by Truckload Carriers Association (TCA) in Division IV (25-49.99 million miles). Each year, TCA recognizes carriers with the most outstanding safety record and safety program. TCA is the only trade association whose collective sole focus is the truckload segment of the motor carrier industry and represents dry van, refrigerated, flatbed, tanker, and intermodal container carriers.
Bay and Bay is a family-owned company and that…
Bay Area Builder DeNova Homes Announces Three New Bay Area New Home Communities
Concord, CA – DeNova Homes, Inc. (http://www.denovahomes.com) announced that construction has begun on three Bay Area new home communities. All communities are scheduled to open in Spring 2011.
“We are very optimistic about the Bay Area new home market in 2011, and after surviving these challenging economic times we are excited to once again be growing our company,” said Lori Sanson, Executive Vice President of DeNova Homes.
The communities, which will include…
Green Bay Packers
As far as the great team of Green Bay Packers is concerned, bland is the new blitz at least when it comes to the preseason. Entering their second year in protective coordinator Dom Capers 3-4 scheme, the Packers are facing a far gentler learning curve to get ready for the regular season. Therefore unlike last year, when the defense was new and Capers felt players had to practice all under…
BOOT CAMP, Round 2: The "Bay Bay Way" Is Back On Track
SAN ANTONIO – After an unexpected rain delay, the game is on again, as Bay Bay's Kids & All Sports Foundation has reteamed with H-E-B for BOOT CAMP: THE FITNESS CHALLENGE and the H-E-B Health and Fitness Fair.
The event, originally announced for September 13, was postponed as Hurricane Ike approached Texas, and has been rescheduled for Saturday, November 1, from 8AM to 12 noon, at the Don Strange Ranch (103…
